Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

  • Quantitative Risk Model for Predicting Likelihood of Recurrence for Oral Cavity Cancer.Scott Doyle (Principal Investigator). NIH. $2,003,024. 4/1/2020-3/1/2024.
  • Collaborative Research: Control of Information Processing and Learning in Neuronal Networks through Light-mediated Programming of Genomic Networks.Yongho Bae (Co-Principal Investigator). National Science Foundation. $366,284. 2/1/2021-1/1/2024.
  • R01: Computational Imaging of Renal Structures for Diagnosing Diabetic Nephropathy.Pinaki Sarder (Principal Investigator). National Institutes of Health. $1,485,400. 9/1/2018-7/1/2023.
  • Biomarker Discovery and Validation in PSP.Olga Pletnikova (Contributor). NIH. $576,476. 8/1/2018-4/1/2023.
  • IOS Preliminary Proposal: Collaborative Research: Morphofunctional Correlates of Ecology in Carnivoran Mammals and the Macroevolutionary Patterns of Ecological Specialization.Scott Doyle (Co-Principal Investigator). National Science Foundation. 8/1/2018-7/1/2021.
  • Networked Nanophotonic Devices for Stem Cell Regulation: From Optogenetics to Optogenomics.Yongho Bae (Co-Principal Investigator). National Science Foundation. $599,067. 8/1/2017-7/1/2021.
  • Computerized histologic image predictor of cancer outcome.John Tomaszewski (Co-Investigator). NIH/Case. $232,187. 7/1/2016-6/1/2021.
  • Mechanotransduction in Vascular Smooth Muscle: Survivin as a Mediator of Stiffness-Induced Responses.Yongho Bae (Principal Investigator). American Heart Association. $231,000. 7/1/2018-6/1/2021.
  • Integration of Physical and Virtual Cadavers in a Hybrid Gross Anatomy Curriculum.Scott Doyle (Co-Investigator). Center for Educational Innovation. $10,000. 5/1/2017-5/1/2021.
  • TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and Biomarker The goal of this study to clarify mechanism of TDP-43 proteinopathy and perform target validation studies and develop biomarkers for ALS-FTD.Olga Pletnikova (Contributor). NIH. $250,000. 4/1/2016-3/1/2021.
  • Pathology Image Informatics Platform for visualization, analysis and management.John Tomaszewski (Co-Investigator). NIH/Case. $101,849. 7/1/2015-6/1/2020.
  • Non-invasive neuronal-vascular stimulation.Yongho Bae (Co-Principal Investigator). Buffalo Blue Sky Project, University at Buffalo. $30,000. 1/1/2019-6/1/2020.
  • Alzheimer’s Disease before plaques and tangles: Abeta-Amyloid Oligomers and the Glymphatic Pathway The goal of this study is to generate novel information on very early development of Alzheimer’s disease to help identify new biomarkers for prevention and.Olga Pletnikova (Contributor). NIH. $150,000. 4/1/2017-3/1/2020.
  • Computational Analysis of Neutrophil Extracellular Traps in Lupus Nephritis Renal Biopsies.Pinaki Sarder (Principal Investigator). CKD Biomarkers Consortium Pilot and Feasibility Program. $75,000. 4/1/2019-3/1/2020.
  • Computational Imaging of Renal Structures for Diagnosing Diabetic Nephropathy.Pinaki Sarder (Principal Investigator). DiaComp Pilot & Feasibility Grant. $100,000. 11/1/2017-10/1/2019.
  • Additional work related to SBIR 1746694: A Blood-Based Test to Identify Patients with Intracranial Aneurysm.John Kolega (Principal Investigator). UB-SBIA. $12,983. 7/1/2018-12/1/2018.
  • A Blood-Based Test to Identify Patients with Intracranial Aneurysm.John Kolega (Principal Investigator). Neurovascular Diagnostics, Inc. $67,761. 1/1/2018-6/1/2018.